KLOW 80mg – 3ml Vial

(GHK-Cu 50mg / BPC-157 10mg / TB-500 10mg / KPV 10mg)

Product Overview

KLOW 80mg is an advanced multi-component research peptide formulation designed for laboratory studies examining synergistic cellular signalling pathways involved in extracellular matrix regulation, tissue remodelling models, and peptide-mediated inflammatory pathway interactions.

This blend combines four well-characterised research peptides:

• GHK-Cu – A copper-chelating tripeptide studied in collagen-associated and gene expression signalling research 
• BPC-157 – A synthetic pentadecapeptide investigated in angiogenic and nitric oxide pathway models 
• TB-500 – A synthetic thymosin beta-4 fragment studied in actin-binding and cellular migration mechanisms 
• KPV – A tripeptide fragment of α-MSH studied in inflammatory signalling and cytokine pathway research 

In controlled in-vitro research systems, KLOW 80mg is commonly utilised to investigate:

• Extracellular matrix pathway interaction 
• Metalloproteinase regulation models 
• Endothelial and fibroblast signalling research 
• Cytoskeletal actin-associated mechanisms 
• Peptide-mediated cytokine pathway modulation 
• Copper-dependent cellular signalling processes 

Supplied in lyophilised form to preserve structural integrity and analytical purity prior to reconstitution.

Key Features

• Multi-peptide research blend (4-component formulation) 
• Combines GHK-Cu, BPC-157, TB-500, and KPV 
• Studied in extracellular matrix and angiogenesis research models 
• Investigated in cellular migration and inflammatory signalling pathways 
• ≥98–99% purity per individual component (HPLC verified) 
• Lyophilised for enhanced stability 
• Total 80mg peptide content per sterile 3ml glass vial 

Blend Composition

• GHK-Cu: 50mg 
• BPC-157: 10mg 
• TB-500: 10mg 
• KPV: 10mg 

Total Peptide Content: 80mg

Component Specifications

🔹 GHK-Cu

• Synonyms: Copper Tripeptide-1; Glycyl-L-Histidyl-L-Lysine Copper 
• Molecular Class: Copper-chelating tripeptide complex 
• Amino Acid Sequence (3-Letter Code):
  Gly-His-Lys (Copper chelated complex) 
• CAS Number: 89030-95-5 
• Purity: ≥99% 
• Appearance: Blue lyophilised powder 

🔹 BPC-157

• Synonyms: Body Protection Compound-157 
• Molecular Class: Synthetic pentadecapeptide 
• Amino Acid Sequence (3-Letter Code):
  Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val 
• CAS Number: 137525-51-0 
• Purity: ≥99% 
• Appearance: White lyophilised powder 

🔹 TB-500

• Synonyms: Thymosin Beta-4 Fragment 
• Molecular Class: Synthetic actin-binding peptide fragment 
• Amino Acid Sequence (3-Letter Code):
  Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Ala-Gly-Glu-Ser 
• CAS Number: 77591-33-4 
• Purity: ≥98–99% 
• Appearance: White lyophilised powder 

🔹 KPV

• Synonyms: Lys-Pro-Val Peptide; α-MSH (11–13) Fragment 
• Molecular Class: Synthetic tripeptide 
• Amino Acid Sequence (3-Letter Code):
  Lys-Pro-Val 
• Molecular Formula: C16H30N4O4 
• Molecular Weight: ~342.4 g/mol 
• CAS Number: 67727-97-3 
• Purity: ≥99% 
• Appearance: White lyophilised powder 

Product Specifications

• Product Name: KLOW 80mg 
• Molecular Class: Multi-peptide research blend 
• Total Net Content: 80mg combined peptides 
• Vial Size: 3ml sterile glass vial 
• Storage Form: Lyophilised peptide blend 
• Intended Use: Laboratory research only 

Handling & Storage Guidelines

Unreconstituted (Lyophilised) Storage:
Store at −20°C for long-term preservation. Short-term storage at 2–8°C is acceptable if intended for use within 1–3 months.

Reconstituted Storage:
After reconstitution, store at 2–8°C and use within 3–6 weeks. Stability may vary depending on solvent selection and handling conditions.

Avoid repeated freeze–thaw cycles. Protect from excessive agitation, heat, and direct light exposure.

Manufacturing & Quality

Each peptide component within KLOW 80mg is manufactured using precision solid-phase peptide synthesis (SPPS) under GMP-aligned laboratory standards.

Each batch undergoes:

• High Performance Liquid Chromatography (HPLC) purity verification 
• Mass spectrometry identity confirmation 
• Analytical quality control prior to release 
• Batch traceability and documentation procedures 

The final blended formulation is prepared under controlled laboratory conditions and released only after meeting strict internal quality specifications.

Legal & Safety Notice

This product is supplied strictly for laboratory research purposes only.

Not for human consumption.
Not for therapeutic, diagnostic, or veterinary use.
Not a licensed medicinal product in the United Kingdom.

The purchaser is responsible for ensuring full compliance with all applicable UK laws and regulations relating to research chemicals.